About this document

Cloos 2009 by luizrsl2905 is a document available to read on EtoBox.

This review discusses the current use of benzodiazepines (BZDs) in treating anxiety disorders, highlighting that while selective serotonin reuptake inhibitors (SSRIs) are recommended as first-line treatments, BZDs remain popular among clinicians due to their rapid onset and effectiveness despite concerns about dependence and side effects. The document emphasizes the importance of considering alternative treatments and the risks associated with long-term BZD use, particularly in vulnerable populations such a

Author

luizrsl2905

Language

EN